Characterization of plasmid-mediated β-Lactamases in fecal colonizing patients in the hospital and community setting in Spain

Microbial Drug Resistance

Volumn 20, Issue 4, 2014, Pages 301-304

  Garrido, Ana ^a   Seral, Cristina ^a,b   Gude, María José ^a   Casado, Cristina ^c,d   González Domínguez, María ^a   Sáenz, Yolanda ^d   Castillo, Francisco Javier ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c UNIVERSITY OF LA RIOJA   (Spain)

^d CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE AMPC; CARBAPENEMASE; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; ANTIINFECTIVE AGENT; ISOENZYME;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECES; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; PLASMID MEDIATED BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; PRIORITY JOURNAL; SPAIN; CHILD; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; EPIDEMIOLOGICAL MONITORING; FEMALE; GENE EXPRESSION; GENETICS; HETEROZYGOTE; MALE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PLASMID; TRANSMISSION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARRIER STATE; CHILD; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGICAL MONITORING; FECES; FEMALE; GENE EXPRESSION; HUMANS; ISOENZYMES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMIDS; SPAIN;

EID: 84905179971     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2013.0109     Document Type: Article

References (21)

1. Carrer, A., L. Lassel, N. Fortineau, M. Mansouri, N. Anguel, C. Richard, and P. Nordmann. 2009. Outbreak of CTXM-15-producing Klebsiella pneumoniae in the intensive care unit of a French hospital. Microb. Drug. Resist. 15:47-54.
2. Castillo García, F.J., C. Seral García, M. Pardos De la Gándara, M.I. Millán Lou, and C. Pitart Ferre. 2007. Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two nonoutbreak periods. Eur. J. Clin. Microbiol. Infect. Dis. 26:77-78.
3. Clinical and Laboratory Standards Institute/NCCLS. 2009. Performance Standards for Antimicrobial Susceptibility. Testing: 19th Informational Supplement. M100-S19.CLSI, Wayne, PA.
4. DAndrea, M.M., F. Arena, L. Pallecchi, and G.M. Rossolini. 2013. CTX-M-type beta-lactamases: a successful story of antibiotic resistance. Int. J. Med. Microbiol. 303:305-317.
5. Díaz, M.A., J.R. Hernández-Bello, J. Rodríguez- Baño, L. Martínez-Martínez, J. Calvo, J. Blanco, and A. Pascual. 2010. Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study. J. Clin. Microbiol. 48:2840-2845.
6. Frakking, F.N., W.C. Rottier, J.W. Dorigo-Zetsma, J.M. van Hattem, B.C. van Hees, J.A. Kluytmans, S.P. Lutgens, J.M. Prins, S.F. Thijsen, A. Verbon, B.J. Vlaminckx, J.W. Cohen Stuart, M.A. Leverstein-van Hall, and M.J. Bonten. 2013. Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-beta-lactamaseproducing bacteria. Antimicrob. Agents Chemother. 57:3092-3099.
7. Gijón, D., T. Curiao, F. Baquero, T.M. Coque, and R. Cantón. 2012. Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients. J. Clin. Microbiol. 50:1558-1563.
8. Gude, M.J., C. Seral, Y. Sáenz, M. Gonzalez-Dominguez, C. Torres, and F.J. Castillo. 2012. Evaluation of four phenotypic methods to detect plasmid-mediated AmpC betalactamases in clinical isolates. Eur. J. Clin. Microbiol. Infect. Dis. 31:2037-2043.
9. Gude, M.J., C. Seral, Y. Sáenz, R. Cebollada, M. González-Domínguez, C. Torres, and F.J. Castillo. 2013. Molecular epidemiology, resistance profiles and clinical features in clinical plasmid-mediated AmpC-producing Enterobacteriaceae. Int. J. Med. Microbiol. 303:553-557.
10. Izdebski, R., A. Baraniak, J. Fiett, A. Adler, M. Kazma, J. Salomon, C. Lawrence, A. Rossini, A. Salvia, J. Vidal Samso, J. Fierro, M. Paul, Y. Lerman, S. Malhotra-Kumar, C. Lammens, H. Goossens, W. Hryniewicz, C. Brun-Buisson, Y. Carmeli, and M. Gniadkowski. 2013. Clonal structure, extended-spectrum beta-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob. Agents Chemother. 57:309-316.
11. Jouini, A., L. Vinue, K.B. Slama, Y. Saenz, N. Klibi, S. Hammami, A. Boudabous, and C. Torres. 2007. Characterization of CTX-M and SHV extended-spectrum betalactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J. Antimicrob. Chemother. 60:1137-1141.
12. Miró, E., J. Aguero, M.N. Larrosa, A. Fernandez, M.C. Conejo, G. Bou, J.J. González-López, N. Lara, L. Martínez- Martínez, A. Oliver, B. Aracil, J. Oteo, A. Pascual, J. Rodríguez-Baño, L. Zamorano, and F. Navarro. 2013. Prevalence and molecular epidemiology of acquired AmpC beta-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 32:253-259.
13. Murray, P., E. Baron, M. Pfaller, F. Tenover, and R. Yolken. 1999. Manual of Clinical Microbiology. 7th ed., American Society for Microbiology, Washington, DC.
14. Pardos de la Gándara, M., C. Seral, J. Castillo García, C. Rubio Calvo, and F.X. Weill. 2011. Prevalence and characterization of extended-spectrum beta-lactamases-producing Salmonella enterica isolates in Saragossa, Spain (2001-2008). Microb. Drug Resist. 17:207-213.
15. Pasteran, F., T. Méndez, L. Guerriero, M. Rapoport, and A. Corso. 2009. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J. Clin. Microbiol. 47:1631-1639.
16. Pérez-Pérez, F.J., and N.D. Hanson. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
17. Pitout, J.D., and K.B. Laupland. 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166.
18. Rodríguez-Baño, J., E. Miró, M. Villar, A. Coelho, M. Gozalo, N. Borrell, G. Bou, M.C. Conejo, V. Pomar, B. Aracil, N. Larrosa, J. Aguero, A. Oliver, A. Fernández, J. Oteo, A. Pascual, and F. Navarro. 2012. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC beta-lactamases. J. Infect. 64:176-183.
19. Sidjabat, H.E., D.L. Paterson, Z.A. Qureshi, J.M. Adams-Haduch, A. OKeefe, A. Pascual, J. Rodríguez-Baño, and Y. Doi. 2009. Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli. Clin. Infect. Dis. 48:739-744.
20. Valverde, A., F. Grill, T.M. Coque, V. Pintado, F. Baquero, R. Cantón, and J. Cobo. 2008. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J. Clin. Microbiol. 46:2796-2799.
21. Valverde, A., T.M. Coque, M.P. Sánchez-Moreno, A. Rollan, F. Baquero, and R. Cantón. 2004. Dramatic increase in prevalence of fecal carriage of extended-spectrum betalactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microbiol. 42:4769-4775.